Brief: Atrys Health Maintains Its Guidance For 2022
Sept 21 (Reuters) - Atrys Health SA ATRY.MC :
* ADJUSTED EBITDA GREW FROM 11.6 MILLION IN FIRST SIX MONTHS
OF
2021 TO 21.8 MILLION FROM JANUARY TO JUNE OF 2022, UP 87%
* ACQUISITION OF BIENZOBAS AND PERFORMANCE OF THE BUSINESS
AREAS
DURING FIRST HALF OF YEAR ALLOW COMPANY TO MAINTAIN ITS GUIDANCE
FOR 2022
Source text for Eikon: ID:nCNM1yFm8m
Further company coverage: ATRY.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))